Kenya recalls Benylin cough syrup over safety concerns

The Pharmacy and Poisons Board (PPB) has directed outlets countrywide to stop the distribution of Benylin, a popular brand of children's cough syrup.

Benylin is a product of South African-based pharmaceutical company, Johnson and Johnson.

In a statement by Pharmacy Board, Chief Executive Fred Siyoi said the drug is under scrutiny over its safety and suitability for the Kenyan market.

The board says the decision was reached at after its Nigerian counterpart recalled the drug over safety issues.

Financial Standard
KRA could miss out on millions in tax revenue from Zuku sale
Financial Standard
Banks rush to comply with CBK rule on spying customer deals
Financial Standard
Varying standards curtail Kenyan insurers' regional foray
Business
Kenya and Algeria to expand trade agreements, Mudavadi says